SCHEMBL28961546

SCHEMBL28961546

COc1ccc(-c2[nH]ccc2Cl)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMO O15229 2/20 0.44
▸ PTGS2 P35354 9/20 0.43
▸ PTGS1 P23219 4/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ LCK P06239 1/20 0.40
▸ MAP4K3 Q8IVH8 1/20 0.40
▸ MAP4K1 Q92918 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ HRH4 Q9H3N8 1/20 0.39
▸ ADORA2A P29274 1/20 0.39
▸ ADORA1 P30542 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12326172 0.80 PTGS2 (0.53) KMOPTGS2PTGS1ALDH1A1HSD17B10
SCHEMBL28602221 0.79 BRD4 (0.49) ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL30729100 0.77 NPC1 (0.51) KMOPTGS2RAB9AMEN1KMT2A
SCHEMBL27074766 0.77 NPC1 (0.51) KMOPTGS2RAB9AMEN1KMT2A
SCHEMBL8195799 0.76 KMO (0.49) KMOPTGS2PTGS1SMN1; SMN2MEN1
SCHEMBL28919428 0.76 ALDH1A1 (0.42) KMOPTGS2PTGS1ALDH1A1MAPT
SCHEMBL28601621 0.76 KMT2A (0.44) MEN1POLBKMT2A
SCHEMBL6002654 0.73 SMPD3 (0.56) KMOALDH1A1MAPTADORA2AADORA1
SCHEMBL4454422 0.73 AHR (0.56) KMOPTGS2PTGS1ALDH1A1HSD17B10
SCHEMBL403698 0.72 ADORA2A (0.55) KMOPTGS2PTGS1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113200983-A Compound with pyrrolopyridine structure, preparation method and medical application 中国药科大学 2021-08-03 — — CN disclosed
Send feedback